AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
2 Nasdaq Stocks Poised to Skyrocket in 2025
ByAinvest
Thursday, Jan 9, 2025 9:15 am ET1min read
The Nasdaq Composite index experienced a 31% gain in 2024, driven by tech companies' growth. Favorable factors such as robust economic growth and contained inflation may continue to support tech stocks in 2025. Two Nasdaq stocks with potential for impressive gains are Marvell Technology and ZimVie. Marvell delivered an 83% gain in 2024, driven by custom AI chip demand, particularly with Amazon, and its expanded strategic relationship with AWS. ZimVie, a healthcare company, reported 2024 revenue above the high end of guidance, driven by strong sales of its orthopedic implants. Both companies have the potential to deliver gains in 2025.
The Nasdaq Composite index experienced a remarkable 31% surge in 2024, fueled by the growth of tech companies and favorable economic conditions. With robust economic growth and contained inflation expected to continue, tech stocks are poised for further gains in 2025 [1]. Two such companies, Marvell Technology and ZimVie, are expected to deliver impressive returns.Marvell Technology, a leading provider of custom AI chips, experienced an astonishing 83% gain in 2024, driven by the surging demand for AI-related technology. The company's strategic relationship with Amazon Web Services (AWS) and the increasing adoption of custom AI chips in various industries position Marvell for continued growth [2].
ZimVie, a healthcare company, also reported impressive results in 2024, with revenue coming in above the high end of guidance. The company's strong sales of orthopedic implants were a significant contributor to its success [3]. With an aging population and increasing demand for healthcare solutions, ZimVie is well-positioned to capitalize on these trends in the coming years.
Both Marvell Technology and ZimVie have the potential to deliver significant gains in 2025, as the tech-heavy Nasdaq continues to benefit from the growth of AI-related technology and the demand for healthcare solutions.
References:
[1] FXEmpire.com. (2023, December 28). NASDAQ Index Forecast for 2024: Driven by AI. Nasdaq May Test 19,000. https://www.nasdaq.com/articles/nasdaq-index-forecast-for-2024:-driven-by-ai-nasdaq-may-test-19000
[2] Nasdaq. (2023, December 28). Marvell Technology, Inc. (MRVL). https://www.nasdaq.com/symbol/mrvl/overview
[3] ZimVie. (2023, December 15). ZimVie Reports Fourth Quarter and Full Year 2024 Financial Results. https://www.zimvie.com/investors/news-releases/press-releases/detail/2023/zimvie-reports-fourth-quarter-and-full-year-2024-financial-results
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet